Skip to content

The study of postoperative intravenous patient-controlled (iv-PCA) analgesia used by oxycodone for Japanese Patients

The study of postoperative intravenous patient-controlled (iv-PCA) analgesia used by oxycodone for Japanese Patients - The study of postoperative intravenous patient-controlled (iv-PCA) analgesia used by oxycodone for Japanese Patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000014951
Enrollment
40
Registered
2014-09-01
Start date
2014-09-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

malignant tumor

Interventions

Change postoperative analgesic agent to use for iv-PCA morphine hydrochloride to oxycodone hydrochloride

Sponsors

Jichi Medical University Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Patients are performed elective operation under general anesthesia for malignant tumor or suspicion. 2. General status of patients are stable and classified into ASA 1 or 2. (object cases for elimination efficacy by hemodialysis contain belong to class 3) 3.Patients choice iv-PCA as methods for postoperative analgesia. 4.Patients stay intensive care unit after surgery and continue direct measurement of arterial pressure.

Exclusion criteria

Exclusion criteria: 1.Difficult patient to obtain consent or judge efficacy by mental disease or symptom. 2.Contrradicated cases for oxycodene hydrochloride (severe respiratory supression, COPD, heart failure, asthma attack, ileus, diarrhea). 3.The value of Hb is under 8mg/dl when the patient entersj intensive care unit. 4.The patient is judged to require blood transfusion after operation. 5.Also, the doctor determine the patient is inadequate to attend the study.

Design outcomes

Primary

MeasureTime frame
improvement of pain

Secondary

MeasureTime frame
respiratory depression, nausea, vomiting, itching, change of drug concentration between before and after hemodialysis

Countries

Japan

Contacts

Public ContactKoki Taira

Jichi Medical University department of anesthesiology and critical care medicine

ktaira@jichi.ac.jp+81-285-58-7383

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026